FDA granted Orphan Drug Designation to Sanofi’s SAR446523, a monoclonal antibody targeting GPRC5D, for relapsed/refractory ...

Detailed price information for Astrazeneca Plc Ord (AZNCF) from The Globe and Mail including charting and trades.

Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...

Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.

YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non ...

Part three of the trial will involve patients at higher risk of cardiovascular disease due to obesity and elevated CRP levels ...

Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience -- -- Topline Results from RECONNECT Phase 2 Trial of RE104 in Postpartum Depression (PPD) Anticipated ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the best low priced pharma stocks to buy now. On June 23, Aclaris Therapeutics initiated a placebo-controlled Phase 1a/1b program for its ...

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, ...

Methods and analysis The PINPOINT study is a phase IV, single-centre, investigator-initiated, prospective, observational study designed to compare the pharmacokinetics and pharmacodynamics of ...

Drug efficacy, safety tied to clear understanding of how the body processes medications.